The 2018 annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) took place from May 22-25 in Paris as usual. The event attracted more than 10,000 interventional cardiologists from all over the world. This congress is an important opportunity for the presentation and discussion of the most important studies. Over 30 late-breaking trials and other key studies were presented this year.
The 2018 annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) took place from May 22-25 in Paris as usual. The event attracted more than 10,000 interventional cardiologists from all over the world. This congress is an important opportunity for the presentation and discussion of the most important studies. Over 30 late-breaking trials and other key studies were presented this year.
interviste
Renal denervation: SPYRAL HTN-ON MED trial, six-month results
Managing trans-catheter aortic valve thrombosis
Latest major advances in interventional cardiology
The shockwave procedure in peripheral artery disease
Efficacia e diffusione delle procedure interventistiche
Euro PCR: an opportunity to improve interventional skills
Giù le liste di attesa con follow up sartoriale post PCI
Low stent thrombosis incidence after PCI
Preview of the TALENT study results
Improving vessel healing after angioplasty
ERIS Study: the importance of functional assessment in PCI
Sirolimus coated balloon in complex PCI
MATISSE and ROCK studies results
Bioabsorbable stents in acute MI, a report from the Swedish Registry
